Market Overview:
The global injectable anthelmintic drugs market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of parasitic infections, rising demand for novel anthelmintic drugs, and growing awareness about the benefits of anthelmintic drugs. Based on type, the global injectable anthelmintic drugs market is segmented into benzimidazoles, piperazine, imidazothiazole, spiroindoles, and others. Benzimidazoles are expected to account for the largest share of this market in 2018 owing to their high efficacy against a wide range of parasites and easy availability. Piperazines are also expected to witness significant growth during the forecast period due their low cost and easy availability. Based on application, the global injectable anthelmintic drugs market is segmented into hospital pharmacies, retail pharmacies, online pharmacies,, veterinary pharmacies,, and others).
Product Definition:
Injectable anthelmintic drugs are used to treat parasitic worm infections. They work by killing the parasites or making them unable to reproduce. Injectable anthelmintics are important for treating serious worm infections, especially in people who are unable to take oral medication.
Benzimidazoles:
Benzimidazoles are a group of drugs that act as an antileishmanial and anti-invectives agent. They are used to treat parasitic diseases such as leishmaniasis, amebiasis, and giardiasis. The active ingredient in all benzimidazole drugs is the same: 5-aminolevulinic acid (5-ALA).
Piperazine:
Piperazine is a piperidine derivative with an aromatic structure. It is colorless and has a mild odor. Piperazine can be formulated in the form of its salts such as hydrochloride, nitrate, fumarate, and others; all are used in veterinary medicine to treat parasitic infections. The most commonly used salt for veterinary use is the hydrochloride which is also known as paromomycin.
The drug was first synthesized by Drs.
Application Insights:
Based on the application, the global injectable anthelmintic drugs market is segmented into hospital pharmacies, retail pharmacies, online pharmacies and veterinary pharmacies. The hospital pharmacy segment dominated the overall market in terms of revenue in 2017. This high share can be attributed to factors such as a large patient base with chronic diseases requiring longterm medication and an increasing number of hospitals across developing countries due to rising healthcare spending.
The veterinary pharmacy segment is expected to witness lucrative growth over the forecast period owing to growing awareness among pet owners about preventative measures for their pets against nematode infection through routine visits at veterinarian clinics or hospitals. Furthermore, an increase in expenditure on preventive care for animals will boost this industry further during future years as these drugs are highly effective against nematodes when used appropriately by vets during treatment procedures or before moving onto another area that may potentially be infested with worms such as cats or dogs.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period owing to favorable reimbursement policies, increasing prevalence of hydramnios and paroxetine hydrochloride-resistant gastric motility disorder, and rising awareness among veterinarians. In addition, new product launches are also anticipated to drive regional growth over the forecast period. For instance, in May 2018 Merck & Co., Inc.; announced about commencing mid-stage clinical trial for a new treatment for canine bloat syndrome based on imidazole structure called Fimpat (also known as OTC MZD1076).
Asia Pacific is expected to witness lucrative growth over the coming years due to rising disposable income coupled with growing pet ownership especially in India and China. Moreover, improving healthcare infrastructure along with an increase in government spending on veterinary health may also contribute toward industry growth over the next eight years.
Growth Factors:
- Increasing prevalence of parasitic infections: The increasing prevalence of parasitic infections is one of the key growth drivers for the injectable anthelmintic drugs market. According to a study by the World Health Organization (WHO), over 1.5 billion people are affected by intestinal parasites, globally. This number is expected to increase in the coming years due to factors such as changing lifestyles, growing population, and increasing travel and trade activities.
- Rising demand for effective anthelmintic drugs: The rising demand for effective anthelmintic drugs is another major growth driver for this market. Intestinal parasites can cause a wide range of health problems, including diarrhea, vomiting, abdominal pain, weight loss, and fever. Thus, there is a growing need for safe and efficacious anthelmintic drugs that can effectively treat these infections.
- Technological advancements in drug development: The technological advancements in drug development are also propelling the growth of this market worldwide . Injectable anthelmintics are being developed with novel modes-of-action that offer better efficacy against various types of intestinal parasites than older generation products currently available in the market . This is likely to boost their adoption rates in future years .
Scope Of The Report
Report Attributes
Report Details
Report Title
Injectable Anthelmintic Drugs Market Research Report
By Type
Benzimidazoles, Piperazine, Imidazothiazole, Spiroindoles, Others
By Application
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Veterinary Pharmacies, Others
By Companies
Novartis, Cipla, Sun Pharmaceutical Industries, Amneal Pharmaceuticals, Zoetis, GlaxoSmithKline, Bayer, Merck, Boehringer Ingelheim International
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
174
Number of Tables & Figures
122
Customization Available
Yes, the report can be customized as per your need.
Global Injectable Anthelmintic Drugs Market Report Segments:
The global Injectable Anthelmintic Drugs market is segmented on the basis of:
Types
Benzimidazoles, Piperazine, Imidazothiazole, Spiroindoles, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Veterinary Pharmacies, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Novartis
- Cipla
- Sun Pharmaceutical Industries
- Amneal Pharmaceuticals
- Zoetis
- GlaxoSmithKline
- Bayer
- Merck
- Boehringer Ingelheim International
Highlights of The Injectable Anthelmintic Drugs Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Benzimidazoles
- Piperazine
- Imidazothiazole
- Spiroindoles
- Others
- By Application:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Veterinary Pharmacies
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Injectable Anthelmintic Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Injectable anthelmintic drugs are medications used to treat parasitic infections, such as roundworm and hookworm. They are typically given by injection into a muscle or under the skin.
Some of the key players operating in the injectable anthelmintic drugs market are Novartis, Cipla, Sun Pharmaceutical Industries, Amneal Pharmaceuticals, Zoetis, GlaxoSmithKline, Bayer, Merck, Boehringer Ingelheim International.
The injectable anthelmintic drugs market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Injectable Anthelmintic Drugs Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Injectable Anthelmintic Drugs Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Injectable Anthelmintic Drugs Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Injectable Anthelmintic Drugs Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Injectable Anthelmintic Drugs Market Size & Forecast, 2018-2028
4.5.1 Injectable Anthelmintic Drugs Market Size and Y-o-Y Growth
4.5.2 Injectable Anthelmintic Drugs Market Absolute $ Opportunity
Chapter 5 Global Injectable Anthelmintic Drugs Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Injectable Anthelmintic Drugs Market Size Forecast by Type
5.2.1 Benzimidazoles
5.2.2 Piperazine
5.2.3 Imidazothiazole
5.2.4 Spiroindoles
5.2.5 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Injectable Anthelmintic Drugs Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Injectable Anthelmintic Drugs Market Size Forecast by Applications
6.2.1 Hospital Pharmacies
6.2.2 Retail Pharmacies
6.2.3 Online Pharmacies
6.2.4 Veterinary Pharmacies
6.2.5 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Injectable Anthelmintic Drugs Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Injectable Anthelmintic Drugs Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Injectable Anthelmintic Drugs Analysis and Forecast
9.1 Introduction
9.2 North America Injectable Anthelmintic Drugs Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Injectable Anthelmintic Drugs Market Size Forecast by Type
9.6.1 Benzimidazoles
9.6.2 Piperazine
9.6.3 Imidazothiazole
9.6.4 Spiroindoles
9.6.5 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Injectable Anthelmintic Drugs Market Size Forecast by Applications
9.10.1 Hospital Pharmacies
9.10.2 Retail Pharmacies
9.10.3 Online Pharmacies
9.10.4 Veterinary Pharmacies
9.10.5 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Injectable Anthelmintic Drugs Analysis and Forecast
10.1 Introduction
10.2 Europe Injectable Anthelmintic Drugs Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Injectable Anthelmintic Drugs Market Size Forecast by Type
10.6.1 Benzimidazoles
10.6.2 Piperazine
10.6.3 Imidazothiazole
10.6.4 Spiroindoles
10.6.5 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Injectable Anthelmintic Drugs Market Size Forecast by Applications
10.10.1 Hospital Pharmacies
10.10.2 Retail Pharmacies
10.10.3 Online Pharmacies
10.10.4 Veterinary Pharmacies
10.10.5 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Injectable Anthelmintic Drugs Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Injectable Anthelmintic Drugs Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Injectable Anthelmintic Drugs Market Size Forecast by Type
11.6.1 Benzimidazoles
11.6.2 Piperazine
11.6.3 Imidazothiazole
11.6.4 Spiroindoles
11.6.5 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Injectable Anthelmintic Drugs Market Size Forecast by Applications
11.10.1 Hospital Pharmacies
11.10.2 Retail Pharmacies
11.10.3 Online Pharmacies
11.10.4 Veterinary Pharmacies
11.10.5 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Injectable Anthelmintic Drugs Analysis and Forecast
12.1 Introduction
12.2 Latin America Injectable Anthelmintic Drugs Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Injectable Anthelmintic Drugs Market Size Forecast by Type
12.6.1 Benzimidazoles
12.6.2 Piperazine
12.6.3 Imidazothiazole
12.6.4 Spiroindoles
12.6.5 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Injectable Anthelmintic Drugs Market Size Forecast by Applications
12.10.1 Hospital Pharmacies
12.10.2 Retail Pharmacies
12.10.3 Online Pharmacies
12.10.4 Veterinary Pharmacies
12.10.5 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Injectable Anthelmintic Drugs Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Injectable Anthelmintic Drugs Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Injectable Anthelmintic Drugs Market Size Forecast by Type
13.6.1 Benzimidazoles
13.6.2 Piperazine
13.6.3 Imidazothiazole
13.6.4 Spiroindoles
13.6.5 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Injectable Anthelmintic Drugs Market Size Forecast by Applications
13.10.1 Hospital Pharmacies
13.10.2 Retail Pharmacies
13.10.3 Online Pharmacies
13.10.4 Veterinary Pharmacies
13.10.5 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Injectable Anthelmintic Drugs Market: Competitive Dashboard
14.2 Global Injectable Anthelmintic Drugs Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Novartis
14.3.2 Cipla
14.3.3 Sun Pharmaceutical Industries
14.3.4 Amneal Pharmaceuticals
14.3.5 Zoetis
14.3.6 GlaxoSmithKline
14.3.7 Bayer
14.3.8 Merck
14.3.9 Boehringer Ingelheim International
